This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Annlia Paganini-Hill, PhD; Victor W. Henderson, MD

Arch Intern Med. 1996;156(19):2213-2217.

Abstract
Background
With Alzheimer disease emerging as a major public health problem, the identification of factors that might prevent this disease are important. Estrogen loss associated with menopause may contribute to the development of Alzheimer disease.

Objective
To evaluate the effects of different estrogen preparations, varying dosages of estrogen, and duration of estrogen replacement therapy on the risk of Alzheimer disease in postmenopausal women.

Study Design and Methods
A case-control study nested within a prospective cohort study of residents of Leisure World Laguna Hills, a retirement community in Southern California. The cohort comprised 8877 women who were first mailed a health survey in 1981. Of the 3760 female cohort members who died between 1981 and 1995, 248 women with Alzheimer disease or other dementia diagnoses likely to represent Alzheimer disease (senile dementia, dementia, or senility) mentioned on the death certificate were identified. Five controls were individually matched to each case according to year of death and year of birth (±1 year).

Results
The risk of Alzheimer disease and related dementia was significantly reduced in estrogen users compared with nonusers (odds ratio, 0.65; 95% confidence interval, 0.49-0.88). The risk was reduced for both oral and nonoral (ie, injections and/or creams) routes of administration. The risk decreased significantly with both increasing dosages (P=.01) and increasing duration (P=.01) of oral therapy with conjugated equine estrogen, the most commonly used estrogen preparation. Within each dose category, the risk decreased with increasing duration of therapy, with the lowest observed risk in long-term users who received high doses (odds ratio, 0.48; 95% confidence interval, 0.19-1.17).

Conclusion
This study suggests that estrogen replacement therapy may be useful for preventing or delaying the onset of Alzheimer disease in postmenopausal women.

Arch Intern Med. 1996;156:2213-2217

Author Affiliations
From the Departments of Preventive Medicine (Dr Paganini-Hill) and Neurology (Dr Henderson), University of Southern California School of Medicine, Los Angeles.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Potential for Estrogens in Preventing Alzheimer's Disease.
Simpkins et al.
Therapeutic Advances in Neurological Disorders 2009;2:31-49.
ABSTRACT  

Estrogens and Alzheimer's Disease: Is Cholesterol a Link?
Etgen
Endocrinology 2008;149:4253-4255.
FULL TEXT  

Incidence of Dementia in Long-term Hormone Users
Petitti et al.
Am J Epidemiol 2008;167:692-700.
ABSTRACT | FULL TEXT  

Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice
Carroll et al.
J. Neurosci. 2007;27:13357-13365.
ABSTRACT | FULL TEXT  

Effects of estrogen against LPS-induced inflammation and toxicity in primary rat glial and neuronal cultures
Tenenbaum et al.
Innate Immunity 2007;13:158-166.
ABSTRACT  

Novel Mechanisms for Estrogen-Induced Neuroprotection.
Singh et al.
Exp. Biol. Med. 2006;231:514-521.
ABSTRACT | FULL TEXT  

Familial Alzheimer disease in Latinos: Interaction between APOE, stroke, and estrogen replacement
Rippon et al.
Neurology 2006;66:35-40.
ABSTRACT | FULL TEXT  

Brain estrogen deficiency accelerates A{beta} plaque formation in an Alzheimer's disease animal model
Yue et al.
Proc. Natl. Acad. Sci. USA 2005;102:19198-19203.
ABSTRACT | FULL TEXT  

Invited Commentary: How Far Can Epidemiologists Get with Statistical Adjustment?
Petitti and Freedman
Am J Epidemiol 2005;162:415-418.
FULL TEXT  

Sex, Hormones, and Alzheimer's Disease
Baum
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2005;60:736-743.
ABSTRACT | FULL TEXT  

Estrogen Therapy Fails to Alter Amyloid Deposition in the PDAPP Model of Alzheimer's Disease
Green et al.
Endocrinology 2005;146:2774-2781.
ABSTRACT | FULL TEXT  

Postmenopausal hormone therapy: from monkey glands to transdermal patches
Davis et al.
J Endocrinol 2005;185:207-222.
ABSTRACT | FULL TEXT  

Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age
Henderson et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:103-105.
ABSTRACT | FULL TEXT  

Both estrogen and raloxifene protect against {beta}-amyloid-induced neurotoxicity in estrogen receptor {alpha}-transfected PC12 cells by activation of telomerase activity via Akt cascade
Du et al.
J Endocrinol 2004;183:605-615.
ABSTRACT | FULL TEXT  

Glia Mediates the Neuroprotective Action of Estradiol on {beta}-Amyloid-Induced Neuronal Death
Sortino et al.
Endocrinology 2004;145:5080-5086.
ABSTRACT | FULL TEXT  

Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease
Iivonen et al.
Neurology 2004;62:1170-1176.
ABSTRACT | FULL TEXT  

Estradiol Attenuates Programmed Cell Death after Stroke-Like Injury
Rau et al.
J. Neurosci. 2003;23:11420-11426.
ABSTRACT | FULL TEXT  

An Estrogen Replacement Therapy Containing Nine Synthetic Plant-Based Conjugated Estrogens Promotes Neuronal Survival
Zhao et al.
Exp. Biol. Med. 2003;228:823-835.
ABSTRACT | FULL TEXT  

Estrogen and Cognitive Functioning in Women
Sherwin
Endocr. Rev. 2003;24:133-151.
ABSTRACT | FULL TEXT  

Adjuvant Breast Cancer Treatment and Cognitive Function: Current Knowledge and Research Directions
Phillips and Bernhard
JNCI J Natl Cancer Inst 2003;95:190-197.
ABSTRACT | FULL TEXT  

Pharmacologic Agents Associated with a Preventive Effect on Alzheimer's Disease: A Review of the Epidemiologic Evidence
in 't Veld et al.
Epidemiol Rev 2002;24:248-268.
FULL TEXT  

Hormone Therapy and Risk of Alzheimer Disease: A Critical Time
Resnick and Henderson
JAMA 2002;288:2170-2172.
FULL TEXT  

The Role of Hormone Replacement Therapy in the Prevention of Alzheimer Disease
Fillit
Arch Intern Med 2002;162:1934-1942.
ABSTRACT | FULL TEXT  

Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease
Suh and Checler
Pharmacol. Rev. 2002;54:469-525.
ABSTRACT | FULL TEXT  

Postmenopausal Hormone Replacement Therapy: Scientific Review
Nelson et al.
JAMA 2002;288:872-881.
ABSTRACT | FULL TEXT  

Prevalence of Dementia in Users of Hormone Replacement Therapy as Defined by Prescription Data
Petitti et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2002;57:M532-538.
ABSTRACT | FULL TEXT  

Neuroprotective and Neurotrophic Efficacy of Phytoestrogens in Cultured Hippocampal Neurons
Zhao et al.
Exp. Biol. Med. 2002;227:509-519.
ABSTRACT | FULL TEXT  

Pharmacokinetics of 17{beta}-Dihydroequilin Sulfate in Normal Postmenopausal Women Under Steady State Conditions
Bhavnani et al.
Reproductive Sciences 2002;9:102-110.
ABSTRACT  

Endogenous Estradiol in Elderly Individuals: Cognitive and Noncognitive Associations
Senanarong et al.
Arch Neurol 2002;59:385-389.
ABSTRACT | FULL TEXT  

Genome and Hormones: Gender Differences in Physiology: Invited Review: Estrogens effects on the brain: multiple sites and molecular mechanisms
McEwen
J. Appl. Physiol. 2001;91:2785-2801.
ABSTRACT | FULL TEXT  

Selective Estrogen Receptor Modulation and Reduction in Risk of Breast Cancer, Osteoporosis, and Coronary Heart Disease
Jordan et al.
JNCI J Natl Cancer Inst 2001;93:1449-1457.
ABSTRACT | FULL TEXT  

The menopause and its treatment in perspective
Al-Azzawi
Postgrad. Med. J. 2001;77:292-304.
FULL TEXT  

Reproductive Period and Risk of Dementia in Postmenopausal Women
Geerlings et al.
JAMA 2001;285:1475-1481.
ABSTRACT | FULL TEXT  

Hormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis
LeBlanc et al.
JAMA 2001;285:1489-1499.
ABSTRACT | FULL TEXT  

Physical Activity and Risk of Cognitive Impairment and Dementia in Elderly Persons
Laurin et al.
Arch Neurol 2001;58:498-504.
ABSTRACT | FULL TEXT  

Alzheimer's Disease in Man and Transgenic Mice : Females at Higher Risk
Turner
Am. J. Pathol. 2001;158:797-801.
FULL TEXT  

Effects of Long-Term Hormone Therapy on Cholinergic Synaptic Concentrations in Healthy Postmenopausal Women
Smith et al.
J. Clin. Endocrinol. Metab. 2001;86:679-684.
ABSTRACT | FULL TEXT  

Gonadal Hormones, Reproductive Age, and Women With Depression
Halbreich
Arch Gen Psychiatry 2000;57:1163-1164.
FULL TEXT  

The Role of Hormone Replacement Therapy in the Prevention of Postmenopausal Heart Disease
Mosca
Arch Intern Med 2000;160:2263-2272.
ABSTRACT | FULL TEXT  

Comparison of Pharmacokinetics of a Conjugated Equine Estrogen Preparation (Premarin) and a Synthetic Mixture of Estrogens (C.E.S.) in Postmenopausal Women
Bhavnani et al.
Reproductive Sciences 2000;7:175-183.
ABSTRACT  

Prospects for Pharmacological Intervention in Alzheimer Disease
Emilien et al.
Arch Neurol 2000;57:454-459.
ABSTRACT | FULL TEXT  

Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial
Mulnard et al.
JAMA 2000;283:1007-1015.
ABSTRACT | FULL TEXT  

Alzheimer disease: protective factors1
Nourhashemi et al.
Am. J. Clin. Nutr. 2000;71:643s-649s.
ABSTRACT | FULL TEXT  

Estrogen for Alzheimer's disease in women: Randomized, double-blind, placebo-controlled trial
Henderson et al.
Neurology 2000;54:295-295.
ABSTRACT | FULL TEXT  

Selective Estrogen Receptor Modulators (SERMs): A First Step in the Development of Perfect Hormone Replacement Therapy Regimen
McDonnell
Reproductive Sciences 2000;7:S10-S15.
ABSTRACT  

Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies
Andersen et al.
Neurology 1999;53:1992-1992.
ABSTRACT | FULL TEXT  

The distribution of endometrial leukocytes and their proliferation markers in trimegestone-treated postmenopausal women compared to the endometrium of the natural cycle: a dose-ranging study
Wahab et al.
Hum Reprod 1999;14:1201-1206.
ABSTRACT | FULL TEXT  

Postmenopausal estrogen replacement therapy and risk of AD: A population-based study
Waring et al.
Neurology 1999;52:965-965.
ABSTRACT | FULL TEXT  

The Relationships Between Age, Sex, and the Incidence of Dementia and Alzheimer Disease: A Meta-analysis
Gao et al.
Arch Gen Psychiatry 1998;55:809-815.
ABSTRACT | FULL TEXT  

Increased Synaptic Sprouting in Response to Estrogen via an Apolipoprotein E-Dependent Mechanism: Implications for Alzheimer's Disease
Stone et al.
J. Neurosci. 1998;18:3180-3185.
ABSTRACT | FULL TEXT  

Geriatric Medicine
Applegate and Pahor
JAMA 1997;277:1863-1864.
 

Estrogen and Dementia
JWatch Psychiatry 1997;1997:16-16.
FULL TEXT  

More Evidence That Estrogen Reduces Alzheimer's Risk
JWatch Women's Health 1996;1996:7-7.
FULL TEXT  

ESTROGEN AND DEMENTIA
JWatch General 1996;1996:2-2.
FULL TEXT  

Estrogen receptor alpha , not beta , is a critical link in estradiol-mediated protection against brain injury
Dubal et al.
Proc. Natl. Acad. Sci. USA 2001;98:1952-1957.
ABSTRACT | FULL TEXT